Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer. - Raynes, George; Stares, Mark; Low, Samantha; Haron, Dhania; Sarwar, Hussain; Abhi, Dhruv; Barrie, Colin; Laird, Barry; Phillips, Iain; MacKean, Melanie (Cancers, 2023)